Amneal Pharmaceuticals, Inc.

8-K Entered a material agreement Aug 3, 2026 8-K Shareholder vote results Jul 31, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jul 30, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Shareholder vote results May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Regulation FD disclosure Apr 22, 2026 10-K Fiscal year ended 2025-12-31 Feb 27, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 27, 2026 8-K Entered a material agreement; Took on a direct financial obligation Feb 3, 2026 8-K Other events Jan 28, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Oct 30, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K/A Shareholder vote results Aug 5, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 5, 2025 8-K Entered a material agreement; Took on a direct financial obligation Aug 1, 2025 8-K Other events Jul 24, 2025 8-K Other events Jul 21, 2025 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Jul 21, 2025 8-K Shareholder vote results May 8, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 2, 2025 8-K Director or officer change Mar 6, 2025 10-K Fiscal year ended 2024-12-31 Feb 28, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Feb 28, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 15, 2025 8-K/A Results of operations (earnings release); Regulation FD disclosure Nov 12, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 8, 2024 8-K Regulation FD disclosure Oct 1, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 9, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Shareholder vote results May 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 3, 2024 10-K Fiscal year ended 2023-12-31 Mar 14, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 1, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 10, 2024